Skip to main content
. 2020 Sep 17;2(2):fcaa134. doi: 10.1093/braincomms/fcaa134

Table 1.

Univariate analysis of the predictors of PrimDC and SecDC in the test cohort

Parameter Prim DC versus No DC
SecDC versus NO DC
Mean (±SD) or OR (95% CI) P-value Mean (±SD) or OR (95% CI) P-value
Age, years 52.9 (±12.6) versus 52.9 (±12.6) 0.0379 49.7 (±10.1) versus 52.9 (±12.6) 0.0008
Sex (female) 1.11 (0.77–1.6) 0.5820 1.56 (0.94–2.6) 0.1054
Prior anticoagulation 0.81 (0.41–1.6) 0.6244 0.67 (0.23–1.98) 0.6272
Arterial hypertension 1.2 (0.82–1.75) 0.3841 1.59 (0.91–2.78) 0.1143
Smoking (history) 0.88 (0.53–1.46) 0.7058 1.0 (0.51–2.13) 0.8565
Diabetes mellitus 0.84 (0.34–2.09) 0.8265 0.34 (0.04–2.53) 0.5018
Hunt and Hess scale (IV–V) 4.54 (3.15–6.54) <0.0001 2.46 (1.48–4.08) 0.0007
Dilated/fixed pupils 6.08 (3.67–10.06) <0.0001 1.46 (0.55–3.89) 0.3995
Fisher scale (III–IV) 30.77 (4.24–223.0) <0.0001 2.17 (0.85–5.58) 0.1322
Aneurysm (anterior circulation) 5.74 (3.29–10.02) <0.0001 2.83 (1.45–5.51) 0.0016
Aneurysm size, mm 8.7 (±4.8) versus 6.7 (±4.2) <0.0001 8.1 (±5.1) versus 6.7 (±4.2) 0.0118
Treatment modality (clipping) 68.14 (32.66 - 142.2) <0.0001 2.05 (1.21–3.46) 0.0110
Acute hydrocephalus 0.88 (0.61–1.27) 0.5096 3.67 (1.64–8.18) 0.0005
Presence of IVH 1.17 (0.83–1.64) 0.3865 1.48 (0.89–2.46) 0.1553
Severity of IVH (Graeb score) 2.89 (±3.8) versus 2.17 (±3.1) 0.1207 2.58 (±3.3) versus 2.17 (±3.1) 0.1771
Presence of ICH 20.07 (13.01–30.95) <0.0001 3.88 (2.29–6.56) <0.0001
ICH volume, ml 38.86 (±35.2) versus 13.9 (±16.8) <0.0001 13.4 (±16) versus 13.9 (±16.8) 0.6165
Rebleeding 3.88 (1.91–7.85) 0.0004 2.79 (0.99–7.87) 0.0595
Early angiographic vasospasm 2.76 (1.62–4.69) 0.0004 3.51 (1.91–6.45) 0.0001
Early Infarction 2.97 (2.07–4.25) <0.0001 4.22 (2.5–7.11) <0.0001
WBC, × 109/l 14.02 (±4.5) versus 13 (±4.7) 0.0068 14.7 (±4.7) versus 13 (±4.7) 0.0052
Haemoglobin, × 101 g/l 12.4 (±2) versus 12.7 (±1.9) 0.1099 12.9 (±1.9) versus 12.7 (±1.9) 0.6074
CRP, × 10−3 g/l 0.7 (±1.6) versus 1.0 (±1.9) 0.1504 1.0 (±2.1) versus 1.0 (±1.9) 0.5202
CSF Interleukin-6, × 10−6 g/l 4.16 (±6.14) versus 3.4 (±6.51) 0.7950 4.39 (±7.3) versus 3.4 (±6.51) 0.9597
CSF cells, × 106/l 2705 (±7204) versus 1229 (±2963) 0.5562 1380 (±1853) versus 1229 (±2963) 0.3275
Troponin-I, 10−9 g/l 0.6 (±2) versus 2.5 (±31.7) 0.2435 0.5 (±1) versus 2.5 (±31.7) 0.9254
Maximal systolic BP, mmHg 161.6 (±22.6) versus 165.4 (±25.8) 0.0513 168.2 (±24.7) versus 165.4 (±25.8) 0.2476
Minimal systolic BP, mmHg 125.5 (±88.6) versus 124.1 (±57.4) 0.2574 122.9 (±24.2) versus 124.1 (±57.4) 0.9612
Mean MAP, mmHg 89.3 (±14.8) versus 90.5 (±14.6) 0.1131 93.1 (±15.3) versus 90.5 (±14.6) 0.2552
Maximal body temperature, °C 37.2 (±0.9) versus 37 (±1.9) 0.5385 37.2 (±0.9) versus 37 (±1.9) 0.3009

For laboratory parameters, the first value at admission was considered. P-values set in boldface indicate statistical significance.

SD = standard deviation; OR = odds ratio; CI = confidence interval; WBC = white blood cells; CRP = C-reactive protein; CSF = cerebrospinal fluid; BP = blood pressure; MAP = mean arterial pressure.